Month: July 2021

The APAC Security Australia COVID-19 Antibody Testing Kit can be offered to Health Care professionals only please register your interest to purchase Rapid Point of Care Test provides COVID-19 antibody screening results in 15 minutes. APAC Security Australia markets an IgM/IgG immunoassay screening device that measures the IgG and IgM response to SARS-CoV-2. The main benefit of this Device is to find out whether a person: Has been infected by SARS-CoV-2. Has an immunological IgG/IgM-response to SARS-CoV-2 either from; Infection Vaccination The answers to these two questions can be of significant benefit, for example aiding decisions around whether a person…

For Medical Practitioners only CLUNGENE COVID-19 IgG/IgM Rapid Test Cassette Point of Care testing APAC Security (APAC) markets an IgM/IgG immunoassay screening device that measures the IgG and IgM response to SARS-CoV-2. The main benefit of this Device is for post disease screening, finding out whether a person: Has been infected by SARS-CoV-2. Has an immunological IgG/IgM-response to SARS-CoV-2 The answers to these two questions can be of significant benefit, for example aiding decisions around whether a person can return to work, travel, or socialise with other people. This can be particularly pertinent in the decision making surrounding at-risk groups,…

For professional healthcare providers and in vitro diagnostic use only. [INTENDED USE] The COVID-19 IgG/IgM Rapid Test Cassette (Device) is a lateral flow immunoassay designed for the qualitative detection of IgG and IgM antibodies to the SARS-CoV-2 virus in whole blood, serum or plasma specimens. The Device provides an aid for identifying persons who may have been exposed to, and developed an immune response to the SARS- CoV-2 virus. [SUMMARY] SARS-CoV-2 is a new strain of coronavirus causing the disease COVID-19 in humans. The symptoms range from a mild respiratory infection to more severe pneumonia with acute respiratory distress. The…